Lichen China Limited (LICN) Financials
A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Oct 10, 2026; every other figure is from the SEC filings on this page. Not financial advice.
Newest figures come from the 20-F for FY2025, filed Apr 28, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the LICN SEC filings page.
Lichen China Limited (LICN) reported $24.5M in revenue for fiscal year 2025, down 40.9% from the prior fiscal year. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 6 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Lichen shifted from a profitable, cash-generating model to shrinking revenue, collapsing margins, and financing-supported cash use in FY2025.
The FY2025 cash shortfall was not caused by heavy capital spending: free cash flow matched operating cash flow at-$17.8M because capital expenditures were$0 . Financing supplied$23.6M while liabilities remained only 0.1x equity, indicating that immediate funding pressure came from operations rather than a heavily debt-funded balance sheet.
Revenue fell from
The balance sheet remained lightly levered, with liabilities of
Financial Health Signals
Scored against operating companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →
Health score ≠ stock price. This rates the quality of Lichen China Limited's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.
Lichen China Limited has an operating margin of -73.7%, meaning the company loses $74 on every $100 of revenue. This results in a profitability score of 9/100. This is down from -11.0% the prior year.
Lichen China Limited's revenue declined 40.9% year-over-year, from $41.5M to $24.5M. This contraction results in a growth score of 3/100.
Lichen China Limited carries a low D/E ratio of 0.07, meaning only $0.07 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 83/100, indicating a strong balance sheet with room for future borrowing.
With a current ratio of 7.73, Lichen China Limited holds $7.73 in current assets for every $1 of short-term obligations. This comfortable liquidity earns a score of 96/100.
Lichen China Limited's operations used $17.8M of cash, and capex of $0 added to the outflow, for a free cash flow shortfall of $17.8M. This results in a cash flow score of 6/100.
Lichen China Limited posts a -31.1% return on equity (ROE), meaning it loses $31 for every $100 of shareholders' equity. This results in a returns score of 16/100. This is down from -8.4% the prior year.
Lichen China Limited scores 2.27, placing it in the grey zone between 1.81 and 2.99. The score is driven primarily by a large market capitalization ($15.6M) relative to total liabilities ($5.0M). This signals moderate financial risk that warrants monitoring.
Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.
Lichen China Limited passes 1 of 7 computable financial strength tests (2 of the nine could not be computed from available data). 1 of 4 profitability signals pass, no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution), neither operating efficiency signal passes.
Lichen China Limited reported a net loss of $22.0M while operations used $17.8M of cash. With neither figure positive, the ratio between the two carries no quality signal.
Key Financial Metrics
Earnings & Revenue
None of these metrics is reported for Q4 2025.
Cash & Balance Sheet
Lichen China Limited held $26.9M in cash as of Q4 2025; long-term debt is not reported for that period.
Not reported for Q4 2025.
Not reported for Q4 2025.
Margins & Returns
None of these metrics is reported for Q4 2025.
Capital Allocation
None of these metrics is reported for Q4 2025.
LICN Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
Not reported in any period shown, so not listed: Revenue, Cost of Revenue, Gross Profit, R&D Expenses, SG&A Expenses, Operating Income, EBITDA, Interest Expense, Income Tax, Net Income, EPS (Basic), EPS (Diluted), Diluted Shares (Avg).
LICN Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q4'2520-F | Q2'256-K | Q4'2420-F | Q2'2410-Q | Q4'2310-K | Q2'2310-Q | Q4'2210-K | Q4'2110-K |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $75.6M-5.3% | $67.2M-7.4% | $79.8M+21.8% | $72.6M+29.2% | $65.5M+40.9% | $56.2M | $46.5M+8.3% | $42.9M |
| Current Assets | $36.2M+6.3% | $28.3M-42.4% | $34.0M-15.3% | $49.2M+65.1% | $40.1M+47.2% | $29.8M | $27.3M+14.1% | $23.9M |
| Cash & Equivalents | $26.9M+0.8% | $22.6M-34.0% | $26.7M+3.3% | $34.2M+81.7% | $25.9M+14.4% | $18.8M | $22.6M+34.2% | $16.8M |
| Short-Term Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Inventory | $0-100.0% | $0-100.0% | $67K-23.0% | $54K-57.8% | $87K-31.5% | $128K | $127K-15.3% | $150K |
| Accounts Receivable | $2.0M-44.6% | $1.4M-34.0% | $3.6M-20.4% | $2.2M-20.7% | $4.5M+25.9% | $2.7M | $3.5M-10.1% | $3.9M |
| Long-Term Investments | $1.7M+1087.6% | $1.2M | $145K | $0 | $0 | $0 | $0 | $0 |
| Goodwill | $791K-82.2% | $4.5M | $4.5M | N/A | $0 | N/A | N/A | N/A |
| Total Liabilities | $5.0M+17.5% | $3.0M+5.2% | $4.3M+3.6% | $2.8M-3.6% | $4.1M-23.8% | $2.9M | $5.4M-11.4% | $6.1M |
| Current Liabilities | $4.7M+9.6% | $2.8M-0.8% | $4.3M+4.4% | $2.8M-1.0% | $4.1M-21.8% | $2.8M | $5.2M-14.4% | $6.1M |
| Non-Current Liabilities | $343K+6760.0% | $176K+2100.0% | $5K-85.3% | $8K-90.7% | $34K-81.5% | $86K | $184K | $0 |
| Total Equity | $70.5M-3.6% | $64.3M-7.9% | $73.2M+19.2% | $69.8M+31.0% | $61.4M+49.4% | $53.3M | $41.1M+11.6% | $36.8M |
| Retained Earnings | $20.1M-52.2% | $32.7M-33.2% | $42.1M-12.7% | $49.0M+16.1% | $48.2M+18.1% | $42.2M | $40.8M+23.7% | $33.0M |
Not reported in any period shown, so not listed: Long-Term Debt.
LICN Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
Not reported in any period shown, so not listed: Operating Cash Flow, Depreciation & Amortization, Stock-Based Compensation, Capital Expenditures, Free Cash Flow, Investing Cash Flow, Financing Cash Flow, Dividends Paid, Share Buybacks.
LICN Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
Not reported in any period shown, so not listed: Gross Margin, Operating Margin, Net Margin, Return on Equity, Return on Assets, Asset Turnover, FCF Margin.
Similar Companies
Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.
| Company | Fiscal year | Revenue | Net income | Net margin | Market cap | Health score |
|---|---|---|---|---|---|---|
| Lichen China Limited LICN | FY2025 | $24.5M | -$22.0M | -89.6% | $15.6M | 36/100 |
| Powell Max Limited PMAX | FY2025 | $6.1M | -$3.0M | -49.3% | $2.5M | 44/100 |
| SMX (Security Matters) Public Limited Company SMX | FY2025 | N/A | -$174.6M | N/A | $4.1M | — |
| NiSun International Enterprise Development Group Co., Ltd. NISN | FY2025 | $5.1M | N/A | N/A | $7.0M | 55/100 |
| Samfine Creation Holdings Group Limited SFHG | FY2025 | $21.8M | -$2.5M | -11.7% | $8.6M | 34/100 |
| Premium Catering (Holdings) Limited PC | FY2025 | $3.3M | -$4.2M | N/A | $16.7M | 39/100 |
Where Lichen China Limited Ranks
Frequently Asked Questions
What is Lichen China Limited's annual revenue?
Lichen China Limited (LICN) reported $24.5M in total revenue for fiscal year 2025. This represents a -40.9% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is Lichen China Limited's revenue growing?
Lichen China Limited (LICN) revenue declined by 40.9% year-over-year, from $41.5M to $24.5M in fiscal year 2025.
Is Lichen China Limited profitable?
No, Lichen China Limited (LICN) reported a net income of -$22.0M in fiscal year 2025, with a net profit margin of -89.6%.
What is Lichen China Limited's EBITDA?
Lichen China Limited (LICN) had EBITDA of -$14.0M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.
What is Lichen China Limited's gross margin?
Lichen China Limited (LICN) had a gross margin of 37.3% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.
What is Lichen China Limited's operating margin?
Lichen China Limited (LICN) had an operating margin of -73.7% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.
What is Lichen China Limited's net profit margin?
Lichen China Limited (LICN) had a net profit margin of -89.6% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.
What is Lichen China Limited's return on equity (ROE)?
Lichen China Limited (LICN) has a return on equity of -31.1% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.
What is Lichen China Limited's free cash flow?
Lichen China Limited (LICN) recorded an outflow of $17.8M in free cash flow during fiscal year 2025. This represents a -218.3% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
What is Lichen China Limited's operating cash flow?
Lichen China Limited (LICN) recorded an outflow of $17.8M in operating cash flow during fiscal year 2025, representing cash used by core business activities.
What are Lichen China Limited's total assets?
Lichen China Limited (LICN) had $75.6M in total assets as of fiscal year 2025, including both current and long-term assets.
What are Lichen China Limited's capital expenditures?
Lichen China Limited (LICN) reported no capital expenditure during fiscal year 2025.
What is Lichen China Limited's current ratio?
Lichen China Limited (LICN) had a current ratio of 7.73 as of fiscal year 2025, which is generally considered healthy.
What is Lichen China Limited's debt-to-equity ratio?
Lichen China Limited (LICN) had a debt-to-equity ratio of 0.07 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is Lichen China Limited's return on assets (ROA)?
Lichen China Limited (LICN) had a return on assets of -29.1% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
What is Lichen China Limited's P/E ratio?
Lichen China Limited (LICN) has no price-to-earnings ratio at the moment: net loss, so no earnings multiple (FY2025). The market capitalization is $15.6M as of Oct 10, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
What is Lichen China Limited's price-to-sales ratio?
Lichen China Limited (LICN) trades at 0.6x sales, its market capitalization divided by revenue of $24.5M revenue, FY2025. The market capitalization is $15.6M as of Oct 10, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
How does Lichen China Limited's liquidity compare with its operating cash outflow?
At the end of fiscal year 2025, Lichen China Limited (LICN) held $28.6M in cash, cash equivalents and investments, and reported an operating cash outflow of $17.8M over that year. Dividing the one by the other, the reported balance equals about 19 months of the outflow reported that year. This is arithmetic over figures already filed, not a projection: it assumes nothing about future spending, financing or operations.
What is Lichen China Limited's Altman Z-Score?
Lichen China Limited (LICN) has an Altman Z-Score of 2.27, placing it in the Grey Zone (moderate risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.
What is Lichen China Limited's Piotroski F-Score?
Lichen China Limited (LICN) has a Piotroski F-Score of 1 out of 7 computable signals; 2 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are Lichen China Limited's earnings high quality?
Lichen China Limited (LICN) reported a net loss of $22.0M while operations used $17.8M of cash. With neither figure positive, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
How financially healthy is Lichen China Limited?
Lichen China Limited (LICN) scores 36 out of 100 on our Financial Health Score, indicating weak standing within its operating companies peer group. The score is a 0-100 composite of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.